Puberty blockers will not be routinely offered to children at new gender clinics
- The UK's National Health Service has prohibited the use of puberty blockers to alter the biology of children for gender transition, except in approved clinical trials.
- Trans identification is recognized as possibly being a transient phase, and the use of puberty blockers and cross-sex hormones for those 16 and older has not yet been approved.
- Other European countries have also become cautious about using puberty blockers and hormones, but the problem remains in the US, where politicians and media are promoting the ideology despite evidence to the contrary.
Insights by Ground AI
Does this summary seem wrong?
0 Articles
0 Articles
All
Left
Center
Right
Coverage Details
Total News Sources0
Leaning Left24Leaning Right14Center15Last Updated11 months agoBias Distribution45% Left
